Analysis of the influence of polymyxin B-immobilized fiber column direct hemoperfusion (PMX) therapy on blood lipid mediators in sepsis patients

Analysis of the influence of polymyxin B-immobilized fiber column direct hemoperfusion (PMX) therapy on blood lipid mediators in sepsis patients - Analysis of the influence of polymyxin B-immobilized fiber column direct hemoperfusion (PMX) therapy on blood lipid mediators in sepsis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032762

Enrollment

Registered

2018-06-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who received PMX treatment for septic shock and agreed with this study by the written document.

Exclusion criteria

Exclusion criteria: Patients who are under 18 years old, pregnant, didn't agree with this study, have the contraindication for anticoagulant use, and are judged inappropriate by the researchers.

Design outcomes

Primary

Measure	Time frame
The relationship between lipid mediators concentration and the effect of blood pressure increase	—

Secondary

Measure	Time frame
age, sex, source disease, APACHE II score, SOFA score, combination therapy(blood purification therapy, steroid therapy, immunoglobulin therapy, etc.), Infection site, infectious species, vital signs	—

Countries

Japan

Contacts

Public ContactYoshiki Masuda

Sapporo Medical University School of Medicine Department of Intensive Care Medicine

miminekko@me.com011-611-2111

Outcome results